CSIMarket
 
Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

Biogen Inc Growth Comparisons

Select each growth Category to receive further Information



BIIB Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) -22.3 % 14.39 % 9.33 % 1.37 %
Q / Q Revenue Growth (Q4 MRQ) -15.51 % 13.1 % 4.76 % 7.65 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -6.49 % 33.85 % 8.08 % -3.75 %
Seq. Revenue Growth (for 12 months ending Q4 TTM) -5.74 % 12.35 % 5.17 % 0.4 %
Revenue 5 Year Average Growth 4.55 % 8.47 % 8.03 % 6.05 %
Expected Revenue Growth (Y/Y) -17 % - 1.89 % 1.03 %


BIIB's Growth Comparisons in IV. Quarter 2020




Biogen Inc 's sharp decrease of -22.3% in sales in the forth quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Biotechnology & Drugs industry with 14.39%, and underperformed the 9.33% Revenue growth in the Healthcare sector. Although both Biotechnology & Drugs industry and Healthcare sector posted higher gains than 1.37% overall market increase, Biogen Inc was trailing overall market in the forth quarter.

Comparing company's Revenue to the third quarter results, sales were lower by -15.51% . On the annual basis, average annual sales growth for Biogen Inc is 4.55%, while S & P 500's including only Businesses with the forth quarter 2020 2020 Results, average yearly sales growth is 6.05% over the past five years.


Growth Rates of BIIB's Income in the forth quarter 2020


BIIB Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - -6.58 % -45.78 % -25.62 %
Seq. Operating Income Change (Q4 MRQ) - -12.75 % -50.18 % -9.46 %
Y / Y Operating Income Growth (Q4 TTM) -35.39 % 3.38 % -16.51 % -24.14 %
Seq. Operating Income Growth (Q4 TTM) -31.66 % 8.9 % -5.36 % -8.71 %
Operating Income 5 Year Avg. Change -1.43 % -6.42 % 0.66 % 2.55 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) -75.17 % -61.56 % -73.68 % -7.84 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) -49.21 % -35.22 % -71.28 % -5.16 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) -31.04 % -38.05 % -28.92 % -30.41 %
Seq. Income from Cont. Ops. Change (Q4 TTM) -21.04 % -23.97 % -19.22 % -2.24 %
Income from Cont. Ops. 5 Year Avg. Change 2.48 % -13.39 % -0.25 % 1.68 %

BIIB Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) -75.17 % -59.66 % -67.74 % -8.28 %
Q / Q Net Income Growth (Q4 MRQ) -49.21 % -27.69 % -64.43 % -6.62 %
Y / Y Net Income Change (Q4 TTM) -31.04 % -37.86 % -30.59 % -30.23 %
Seq. Net Income Change (Q4 TTM) -21.04 % -23.87 % -17.97 % -2.35 %
Net Income 5 Year Avg. Growth 2.48 % -13.4 % 0.14 % 2.01 %

BIIB's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) -71.22 % -65.78 % -73.68 % -7.84 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) -47.77 % -39.27 % -71.28 % -5.16 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) -22.28 % - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) -19.08 % 13.17 % 19.05 % 3.58 %
EPS from Cont. Ops. 5 Year Avg. Growth 10.08 % -21.48 % -0.25 % 1.68 %



BIIB EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) -71.27 % -64.09 % -67.74 % -8.28 %
Q / Q EPS Net Growth (Q4 MRQ) -47.89 % -32.21 % -64.43 % -6.62 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - 95.95 % -49.1 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) -19.08 % 76.88 % 16.27 % -37.42 %
EPS Net 5 Year Avg. Change 10.08 % -13.4 % 0.14 % 2.01 %
Expected EPS Growth (Y/Y) -41.63 % - 123.59 % 14.11 %



As Biogen Inc 's income per share faded by -71.27% year on year in the forth quarter, Biotechnology & Drugs industry fell only by -64.09%, Biogen Inc 's forth quarter performance was trailing Biotechnology & Drugs, and underperformed the -67.74% EPS drop in the Healthcare sector. Weak forth quarter income per share, in Biotechnology & Drugs industry and within the Healthcare sector, were reflected in Biogen Inc results which underperformed overall market.

Bottom-line fell by -47.89% from the third quarter results. Comparing the annual growth, income per share of 10.08% on average in last five years, to the S & P 500's, including only Businesses with the forth quarter 2020 earnings, average yearly income per share growth is 2.01%. Biogen Inc grew faster than the market.

BIIB Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -37.08 % 7.98 % -33.68 %
Seq. Free Cash Flow Change (Q4 MRQ) - -28.17 % 8.84 % 74.21 %
Y / Y Free Cash Flow Change (Q4 TTM) 79.96 % 19.1 % 35.56 % -21.84 %
Seq. Free Cash Flow Change (Q4 TTM) -35.49 % 1.55 % 18.96 % -11.55 %
Free Cash Flow 5 Year Avg. Change 11.04 % 2.03 % 11.19 % 10.25 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - 388.73 %
Seq. Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) - - -51.33 % 1778.23 %
Seq. Net Cash Flow Change (Q4 TTM) - - -21.79 % 14.94 %
Net Cash Flow 5 Year Avg. Change - - 18.05 % 125.54 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -61.94 % -13.23 % 14.79 % -2.18 %
Seq. Capital Expenditures Change (Q4 MRQ) 20.1 % -17.52 % 22.03 % 48.98 %
Y / Y Capital Expenditures Change (Q4 TTM) - -11.02 % 9.98 % -10.38 %
Seq. Capital Expenditures Change (Q4 TTM) -25.64 % -1.76 % 9.35 % -0.33 %
Capital Expenditures 5 Year Avg. Change - - 271.09 % 79.79 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NLS's Profile

Stock Price

NLS's Financials

Business Description

Fundamentals

Charts & Quotes

NLS's News

Suppliers

NLS's Competitors

Customers & Markets

Economic Indicators

NLS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071